NSE filing, NSE: NIDAN. Summary written from the filing by ALFA Finder's alert engine.
Nidan Laboratories And Healthcare Ltd: key numbers
- Share price
- ₹13.00
- Market cap
- ₹18.07 Cr
- Revenue (annual)
- ₹25.54 Cr
- Net profit (annual)
- ₹1.51 Cr
- P/E (TTM)
- 12.0×Sector 52.0×
- Promoter holding
- 57.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nidan Laboratories And Healthcare Ltd
All →Nidan Laboratories And Healthcare Other Announcement
Nidan Laboratories and Healthcare Limited submitted a non-applicability intimation for Corporate Governance reports. The company is exempt under SEBI Regulation 15 due to its SME listing.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited conducted its 26th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statement adoption and director re-appointments.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited will hold its 26th Annual General Meeting on September 28, 2026. The company has submitted its Annual Report for FY 2025-26.
Nidan Laboratories And Healthcare Annual General Meeting
Nidan Laboratories and Healthcare Limited will convene its 26th Annual General Meeting on September 28, 2026. The board also approved book closure and e-voting schedules.
Nidan Laboratories And Healthcare Board Meeting Outcome
Nidan Laboratories approved FY26 audited financial results and re-appointed independent directors and statutory auditors. These board decisions ensure operational continuity and regulatory compliance.
Nidan Laboratories And Healthcare Management Change
Nidan Laboratories re-appointed Nilesh Bide and Abhinay Nerurkar as Independent Directors for five-year terms. These appointments ensure continued board stability and regulatory compliance.
- Execution
- 60 months
Other board meeting date announcements
All →Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.